Risk factors for postoperative pancreatic fistula in the Era of pasireotide

Kristin C. Potter, Thomas L. Sutton, Jack O'Grady, Erin W. Gilbert, Rodney Pommier, Skye C. Mayo, Brett C. Sheppard

Research output: Contribution to journalArticlepeer-review


Introduction: Postoperative pancreatic fistulas (POPFs) remain common; POPFs frequently require intervention, termed clinically-relevant POPFs (crPOPFs). Pasireotide is increasingly used to prevent POPF, however, risk factors for POPF in this population remain unexplored. Methods: Patients undergoing pancreatectomy with perioperative pasireotide from 2013 to 2020 were identified from our institutional National Surgical Quality Improvement Project database. Logistic regression was utilized to identify risk factors associated with POPF. Results: One-hundred patients were identified; 26 (26%) underwent distal pancreatectomy with the remainder undergoing pancreaticoduodenectomy. Thirty (30%) experienced POPF, with 21 crPOPFs. Only current smoking was significantly associated with crPOPF (OR 3.79, p = 0.04). Of 30 patients with a firm gland, none experienced crPOPF. Twenty-five received a partial course of pasireotide; 7/25 (28%) crPOPFs occurred versus 14/75 (19%) in patients receiving a full course (p = 0.38). Conclusion: Shortened courses of pasireotide do not increase crPOPF risk; selective discontinuation may be suitable in low-risk patients. Smoking cessation should be encouraged.

Original languageEnglish (US)
Pages (from-to)733-736
Number of pages4
JournalAmerican journal of surgery
Issue number2
StatePublished - Aug 2022


  • Distal pancreatectomy
  • Pancreatic resection
  • Pancreaticoduodenectomy
  • Pasireotide
  • Postoperative pancreatic fistula
  • Risk factor

ASJC Scopus subject areas

  • Surgery


Dive into the research topics of 'Risk factors for postoperative pancreatic fistula in the Era of pasireotide'. Together they form a unique fingerprint.

Cite this